Logo

Spain's BlackBio Raises $3M

Jan 21, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Spanish personalized medicine company BlackBio has raised €3 million ($4.1 million) through private and public funding, it announced on Thursday.

The funds will be used to continue development of diagnostic tools and international expansion, it said. Investors in the round include Inibsa Laboratories and NanoBiz.

The company, based in Madrid, Spain, develops products based on genetics, genomics, and proteomics and among products it has available is its BlackZyme DNA Polymerase for DNA amplification and a diagnostic test for fungal infections.

Filed under

Diagnostics
Proteomics & Protein Research
proteomics
ABRF
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.